Nanomedicine ZPH technology offers strategies for cancer treatment. It could be one or the integration of several paths below.
Nanomedicine ZPH technology offers strategies for cancer treatment. It could be one or the integration of several paths below.
What if it was none of these, and a completely new #solution?
New anti-cancer mechanisms are often highly impactful, both from a scientific and business perspective.
1- Blocks the PD-1 receptor on T cells, enhancing the immune system's ability to attack cancer cells.
2- Inhibits cyclin-dependent kinases 4 and 6, preventing cell cycle progression and tumor growth.
3- Blocks tyrosine kinase enzymes, interrupting signaling pathways that promote cancer cell growth.
4- Binds to specific antigens on cancer cells, marking them for destruction by the immune system.
5- Blocks the proteasome, leading to the accumulation of proteins that induce cancer cell death.
6- Inhibits poly (ADP-ribose) polymerase, preventing DNA repair in cancer cells.
7- Inhibits the formation of new blood vessels that supply the tumor with nutrients.
8- Inhibits topoisomerase enzymes, preventing DNA replication and transcription.
9- Disrupts microtubule function, inhibiting cell division.
10- Blocks or modulates hormone receptors, slowing the growth of hormone-sensitive tumors.
11- Blocks the BCL-2 protein, promoting apoptosis in cancer cells.
12- Inhibits histone deacetylases, altering gene expression to inhibit cancer cell growth.
13- Uses genetically modified viruses to selectively infect and kill cancer cells.
14- Enhances the patient's own immune cells to better attack cancer cells.
15- Alters epigenetic marks to change the expression of genes involved in cancer.
16- Blocks vascular endothelial growth factor, reducing blood supply to the tumor.
17- Inhibits DNA methyltransferases, leading to reactivation of tumor suppressor genes.
18- Modulates the immune system to enhance its anti-cancer activity.
19- Genetically engineers T cells to express receptors specific to cancer cell antigens.
20- Inhibits checkpoint kinases, disrupting the cell cycle in cancer cells.
Nanomedicine & Nanodrugs ZPH GmbH | Deutschland
